Literature DB >> 10433941

Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.

E Berti1, D Tomasini, M H Vermeer, C J Meijer, E Alessi, R Willemze.   

Abstract

Cutaneous T cell lymphomas (CTCL) generally have the phenotype of CD3+, CD4+, CD45RO+ memory T cells. CTCL expressing a CD8+ T cell phenotype are extremely rare and ill-defined. To elucidate whether these CD8+ CTCL represent a distinct disease entity, the clinical, histological, and immunophenotypical features of 17 CD8+ CTCL were reviewed. None of the 17 cases expressed markers characteristic of natural killer cells or gamma/delta T cells. Nine of 17 cases showed the characteristic clinical and histological features as well as clinical behavior of well defined types of CTCL, such as mycosis fungoides (2 cases), pagetoid reticulosis (2 cases), lymphomatoid papulosis (2 cases), and CD30+ large T cell lymphoma (2 cases), all of which usually express a CD4+ T cell phenotype, and 1 case of subcutaneous panniculitis-like T cell lymphoma. The other 8 cases formed a homogeneous group showing a distinctive set of clinicopathological and immunophenotypical features, not consistent with that of other well defined types of CTCL. Clinical characteristics included presentation with generalized patches, plaques, papulonodules, and tumors mimicking disseminated pagetoid reticulosis; metastatic spread to unusual sites, such as the lung, testis, central nervous system, and oral cavity, but not to the lymph nodes; and an aggressive course (median survival, 32 months). Histologically, these lymphomas were characterized by band-like infiltrates consisting of pleomorphic T cells or immunoblasts, showing a diffuse infiltration of an acanthotic epidermis with variable degrees of spongiosis, intraepidermal blistering, and necrosis. The neoplastic cells showed a high Ki-67 proliferation index and expression of CD3, CD8, CD7, CD45RA, betaF1, and TIA-1 markers, whereas CD2 and CD5 were frequently lost. Expression of TIA-1 pointed out that these lymphomas are derived from a cytotoxic T cell subset. The results of this and other studies reviewed herein suggest that these strongly epidermotropic primary cutaneous CD8+ cytotoxic T cell lymphomas represent a distinct type of CTCL with an aggressive clinical behavior.

Entities:  

Mesh:

Year:  1999        PMID: 10433941      PMCID: PMC1866866          DOI: 10.1016/S0002-9440(10)65144-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

1.  OKT8-reactive cell mycosis fungoides.

Authors:  K Ohkohchi; S Aiba; H Tagami
Journal:  Arch Dermatol       Date:  1986-01

2.  Heterogeneity of cutaneous T-cell lymphoma. Phenotypic and ultrastructural characterization of four unusual cases.

Authors:  K Jimbow; K Maeda; Y Ito; O Ishida; T Takami
Journal:  Cancer       Date:  1985-11-15       Impact factor: 6.860

3.  Phenotypic characterization of skin-infiltrating cells in pagetoid reticulosis by monoclonal antibodies.

Authors:  M Gonzalez; M Martin-Pascual; J San Miguel; M D Caballero; A López Borrasca
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Woringer-Kolopp disease (pagetoid reticulosis). Four cases with histopathologic, ultrastructural, and immunohistologic observations.

Authors:  D G Deneau; G S Wood; J Beckstead; R T Hoppe; N Price
Journal:  Arch Dermatol       Date:  1984-08

6.  CD8+ cutaneous T-cell lymphoma with pagetoid epidermotropism and angiocentric and angiodestructive infiltration.

Authors:  Y Fujiwara; Y Abe; M Kuyama; J Arata; T Yoshino; T Akagi; K Miyoshi
Journal:  Arch Dermatol       Date:  1990-06

7.  Death due to splenic rupture in suppressor cell mycosis fungoides: a case report.

Authors:  S R Bennett; J P Greer; R S Stein; A D Glick; J B Cousar; R D Collins
Journal:  Am J Clin Pathol       Date:  1984-07       Impact factor: 2.493

8.  T cells and T-cell subsets in mycosis fungoides and parapsoriasis. A study of 18 cases with anti-human T-cell monoclonal antibodies and histochemical techniques.

Authors:  S A Buechner; R K Winkelmann; P M Banks
Journal:  Arch Dermatol       Date:  1984-07

9.  Subpopulations of T lymphocytes in a patient with fulminant mycosis fungoides.

Authors:  J R Jensen; K Thestrup-Pedersen
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

10.  A case of pagetoid reticulosis bearing the T cytotoxic suppressor surface marker on the lymphoid infiltrate: further evidence that pagetoid reticulosis is not a variant of mycosis fungoides.

Authors:  R M Mackie; M L Turbitt
Journal:  Br J Dermatol       Date:  1984-01       Impact factor: 9.302

View more
  29 in total

1.  CD8+ Lymphomatoid Papulosis.

Authors:  Ji Hyun Sim; You Chan Kim
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

Review 2.  Cutaneous T-cell Lymphoma.

Authors:  Melissa Pulitzer
Journal:  Clin Lab Med       Date:  2017-09       Impact factor: 1.935

Review 3.  Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Authors:  Meenal Kheterpal; Neha Mehta-Shah; Pooja Virmani; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

4.  Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid.

Authors:  Joon Lee; You Jin Yang; Jung-In Kim; Ji-Hye Park; Won-Serk Kim
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

5.  Unusual variants of mycosis fungoides.

Authors:  Pooja Virmani; Patricia L Myskowski; Melissa Pulitzer
Journal:  Diagn Histopathol (Oxf)       Date:  2016-05-21

6.  Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.

Authors:  Paola Rivera-Munoz; Anouchka P Laurent; Aurelie Siret; Cecile K Lopez; Cathy Ignacimouttou; Melanie G Cornejo; Olivia Bawa; Philippe Rameau; Olivier A Bernard; Philippe Dessen; Gary D Gilliland; Thomas Mercher; Sébastien Malinge
Journal:  Blood Adv       Date:  2018-07-10

7.  Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.

Authors:  Joan Guitart; M Estela Martinez-Escala; Antonio Subtil; Madeleine Duvic; Melissa P Pulitzer; Elise A Olsen; Ellen Kim; Alain H Rook; Sara S Samimi; Gary S Wood; Michael Girardi; Jacqueline Junkins-Hopkins; Doina S Ivan; M Angelica Selim; Kimberly A Sable; Pooja Virmani; Laura B Pincus; Michael T Tetzlaff; Jinah Kim; Youn H Kim
Journal:  Mod Pathol       Date:  2017-01-27       Impact factor: 7.842

Review 8.  [Treatment of rare cutaneous T‑cell lymphoma and blastic plasmacytoid dendritic cell neoplasm].

Authors:  U Wehkamp; M Weichenthal
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

9.  Diffuse eruptive ulcerated plaques.

Authors:  Shamir Geller; Melissa Pulitzer; Patricia L Myskowski
Journal:  Int J Dermatol       Date:  2018-04-24       Impact factor: 2.736

10.  Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.

Authors:  Keisuke Kato; Yukiko Oh; Junko Takita; Yuji Gunji; Chie Kobayashi; Ai Yoshimi; Tomohei Nakao; Mio Noma; Kazutoshi Koike; Akira Morimoto; Shigeko Iijima; Hiroshi Hojo; Masahiro Tsuchida
Journal:  Int J Hematol       Date:  2015-12-16       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.